DYAI DYADIC INTERNATIONAL INC — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$0.71

Period return

-0.28 (-28.28%)

Volume

79.6K

2026-06-05O $0.7 H $0.72 L $0.69 C $0.71MA5 $0.72MA20 $0.73MA60 $0.79MA120 $0.83

6M · 124 barsYahoo Finance · USD2025-12-08 → 2026-06-05

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2024. 11. 14.LowBUY2 years ago
HC Wainwright & Co.: Buy
US analyst rating / recommendation change.
2024. 07. 08.LowBUY2 years ago
HC Wainwright & Co.: Buy
US analyst rating / recommendation change.
2023. 11. 13.LowBUY3 years ago
HC Wainwright & Co.: Buy
US analyst rating / recommendation change.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Consensus PT $6 · 2 analysts

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; and sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Sector: Healthcare
Industry: Biotechnology
HQ: Jupiter, FL, United States
Fiscal year end: —
Employees: 5
IPO date: —

View details →

2023. 05. 24.LowBUY3 years ago

HC Wainwright & Co.: Buy